Skip to main content

Table 2 Dynamic changes of cytokines after bone marrow-derived stem cells (BMSCs) transplantation

From: Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17

Cytokines

HC

Weeks after BMSCs transplantation

Baseline

4w

12w

24w

36w

48w

TNF-α

1.8(1.2)

36.2(7.6)a

34.1(12.3)

38.3(9.2)

32.4(5.3)

31.6(2.5)

32.5(5.7)

IFN-γ

3.0(1.1)

2.0(0.8)

4.5(1.3)

1.0(0.7)

1.7(0.8)

2.6(0.4)

3.7(1.1)

IL-12

3.2(0.6)

23.2(1.4)a

21.4(2.1)

18.9(1.7)

20.1(2.2)

19.6(1.5)

20.5(1.2)

IL-13

5.6(1.4)

5.7(2.0)

6.1(1.2)

7.5(2.1)

6.0(1.5)

5.8(1.2)

5.7(1.5)

TGF-β1

8.9(1.3)

23.4(8.3)a

26.5(7.6)

18.2(6.2)

21.6(3.7)

19.5(9.1)

22.2(4.3)

IL-17

21.2(18.9)

216.4(109.3)a

269.8(112.4)

189.0(108.2)

106.1(92.3)b

118.2(102.9)b

57.0(32.7)b

IL-8

17.2(10.3)

131.4(59.3)a

142.9(71.5)

129.3(50.2)

150.2(48.2)

136.5(32.7)

132.4(70.2)

  1. Values are expressed as the mean (standard deviation).
  2. ap<0.05 in comparison with HC; bp<0.05 in comparison with Baseline.
  3. HC, healthy controls; Baseline, 1 week before transplantation.